Mark Mossler, Chief Accounting Officer: C4 Therapeutics CCCC Planned sale · Filed 05/28

Trade details

Type: Planned sale notice
Stock: C4 Therapeutics CCCC
Person: Mark MosslerChief Accounting Officer
Planned sale date: 26/05/27
Filed: 26/05/28

$35.5K to be sold

C4 Therapeutics trades, last 26 weeks

What else happened in C4 Therapeutics around then

Filed or reported within 30 days of the trade day · 04/27~06/26

Mark Mossler's recent trades

Mark MosslerChief Accounting Officer
Planned saleC4 Therapeutics
Planned sale
C4 Therapeutics
CCCC
$17.6K
4,139 sh
$17.6K
Filed 08/14
Traded 08/14
Mark MosslerChief Accounting Officer
Planned saleC4 Therapeutics
Planned sale
C4 Therapeutics
CCCC
$61.1K
15,000 sh
$61.1K
Filed 08/13
Traded 08/13
Mark MosslerChief Accounting Officer
Planned saleC4 Therapeutics
Planned sale
C4 Therapeutics
CCCC
$76.7K
19,519 sh
$76.7K
Filed 08/12
Traded 08/12

Mark Mossler, CAO — plans to sell 9,087 sh of C4 Therapeutics CCCC · $35.5K · around 05/27 | Whalegun